An observational study in Hemorrhagic Fever, sponsored by Cepheid. Completed at 1 site in United States. Open to participants aged 14 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-27.
Sponsored by Cepheid · Observational
A multi-site observation study that was conducted a geographically diverse sites across the United States
Capillary and venous whole blood specimens were prospectively collected from consented individuals symptomatic or asymptomatic of fever
76 studies on the registry are indexed under Hemorrhagic Fevers, Viral; 10 are open to participants now.
This study's enrollment of 408 is above the median of 269 across 14 observational studies indexed under Hemorrhagic Fevers, Viral.
Browse Hemorrhagic Fevers, Viral studies →Cepheid is the lead sponsor of 10 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Whole blood specimens collected from blood donors symptomatic or asymptomatic of fever
Exclusion Criteria:
whole blood specimens from individuals asymptomatic or symptomatic of fever
Diagnostic Test: Xpert Hemorrhagic Fever test
Detection and identification of RNA from multiple viruses from whole blood specimens
Clinical performance comparing Xpert Hemorrhagic Fever to known status of specimens
Xpert test compared to expected status
Time frame: Clinical Performance assessed in specimens collected at Baseline
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cepheid